Coronary heart disease is a serious condition that affects millions of people. It can lead to heart attacks and other life-threatening problems. A recent narrative review looked at whether traditional Chinese medicine and probiotics could help manage this disease. The authors suggest that using these treatments alone or together might be a promising direction for future prevention and management. This approach could represent a new way to handle the condition for patients who need options beyond standard care.
However, the evidence is not yet strong enough to make big claims. The review found that there is limited clinical evidence to support these treatments right now. The studies looked at were not consistent, making it hard to draw firm conclusions. The treatments themselves were not standardized, meaning different versions of traditional Chinese medicine were used in different ways. This lack of consistency makes it difficult to know exactly what works for everyone.
There are also unresolved long-term safety issues that need more attention. We do not fully understand how different people react to these treatments because their gut bacteria vary so much. Because of these gaps, doctors cannot yet recommend these therapies as a standard fix. More research is needed to prove they are safe and effective over time before they become a common part of treatment plans.
